The DOI matches its Crossref record; 241 of the 241 references it cites were found in a registry or an index.
Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer’s Disease and Amyloid Neuroprotection
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 2×
“…upon the discovery that A 56*, a form whose molecular weight is consistent with its being a dodecamer, can be isolated from the cerebrospinal fluid of transgenic mice expressing human APP and, when injected into rats, rapidly and reversibly induced impaired maze performance (Lesné et al., 2006).”
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“Biochemical analysis of brains of patients with AD reveals deficits in nAChRs, an increase in butyrylcholinesterase, reduction in ACh, and attenuated activity of cholinergic synthetic [choline acetyltransferase (ChAT)] and inactivating (AChE) enzymes (Bartus et al., 1982; Francis et al., 1999).”
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 1×
“A , through 7 nAChRs, increases Ca2 , which phosphorylates NMDARs via calcineurin and protein tyrosine phosphatase, nonreceptor type 5 (striatum-enriched) (Snyder et al., 2005).”
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
de Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818
Presenilin is required for activity and nuclear access of Notch in Drosophila
Struhl, G., & Greenwald, I. (1999) · Nature · doi:10.1038/19091 · Cited by 796
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
Levitan, D., & Greenwald, I. (1995) · Nature · doi:10.1038/377351a0 · Cited by 705
β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
Zheng, H., Jiang, M., Trumbauer, M. E., Sirinathsinghji, D. J. S., Hopkins, R., Smith, D. W., Heavens, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 704
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Amyloid β-Protein Assembly and Alzheimer Disease
Roychaudhuri, R., Yang, M., Hoshi, M. M., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800036200 · Cited by 615
Poirier, J., Delisle, M. C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., & Gilfix, B. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12260 · Cited by 595
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
Deshpande, A., Mina, E., Glabe, C., & Busciglio, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 494
Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
Ye, Y., Lukinova, N., & Fortini, M. E. (1999) · Nature · doi:10.1038/19096 · Cited by 489
Jackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462
Nagele, R. G., D’Andrea, M. R., Anderson, W. J., & Wang, H.-Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00460-2 · Cited by 455
Iijima, K., Liu, H.-P., Chiang, A.-S., Hearn, S. A., Konsolaki, M., & Zhong, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400895101 · Cited by 440
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415
Hendrie, H. C., Ogunniyi, A., Hall, K. S., Baiyewu, O., Unverzagt, F. W., Gureje, O., Gao, S., Evans, R. M., Ogunseyinde, A. O., Adeyinka, A. O., et al. (2001) · JAMA · doi:10.1001/jama.285.6.739 · Cited by 398
Bertrand, D., Galzi, J. L., Devillers-Thiéry, A., Bertrand, S., & Changeux, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 391
D'Andrea, M. R., Nagele, R. G., Wang, H., Peterson, P. A., & Lee, D. H. S. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01082.x · Cited by 390
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A. I., Gubb, D. C., & Lomas, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.025 · Cited by 351
Finder, V. H., & Glockshuber, R. (2007) · Neurodegenerative Diseases · doi:10.1159/000100355 · Cited by 348
Linking Calcium to Aβ and Alzheimer's Disease
Green, K. N., & LaFerla, F. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.013 · Cited by 326
Kumar-Singh, S., Theuns, J., Van Broeck, B., Pirici, D., Vennekens, K., Corsmit, E., Cruts, M., Dermaut, B., Wang, R., & Van Broeckhoven, C. (2006) · Human Mutation · doi:10.1002/humu.20336 · Cited by 323
Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity
Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420205 · Cited by 321
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318
A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk
Dreses-Werringloer, U., Lambert, J.-C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.048 · Cited by 318
Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317
Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
Ginsberg, S. D., Hemby, S. E., Lee, V. M.-Y., Eberwine, J. H., & Trojanowski, J. Q. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<77::aid-ana12>3.0.co;2-a · Cited by 315
Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model
Link, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00224-5 · Cited by 301
A Gene Expression Profile of Alzheimer's Disease
Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., & Somogyi, R. (2001) · DNA and Cell Biology · doi:10.1089/10445490152717541 · Cited by 300
β-Amyloid1–42Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice
Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 290
Meunier, J., Ieni, J., & Maurice, T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706927 · Cited by 288
A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster
Finelli, A., Kelkar, A., Song, H.-J., Yang, H., & Konsolaki, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.001 · Cited by 287
A decade of modeling Alzheimer's disease in transgenic mice
MCGOWAN, E., ERIKSEN, J., & HUTTON, M. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.007 · Cited by 287
Culetto, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.869 · Cited by 287
Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila
Greeve, I., Kretzschmar, D., Tschäpe, J.-A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R. M., & Reifegerste, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0283-04.2004 · Cited by 287
Guan, Z., Zhang, X., Ravid, R., & Nordberg, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740237.x · Cited by 285
Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl gene
Luo, L., Tully, T., & White, K. (1992) · Neuron · doi:10.1016/0896-6273(92)90024-8 · Cited by 280
Simone, R. D., Ajmone‐Cat, M. A., Carnevale, D., & Minghetti, L. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-4 · Cited by 275
Halvard Grønlien, J., Håkerud, M., Ween, H., Thorin-Hagene, K., Briggs, C. A., Gopalakrishnan, M., & Malysz, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035410 · Cited by 271
Lord, A., Kalimo, H., Eckman, C., Zhang, X.-Q., Lannfelt, L., & Nilsson, L. N. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.007 · Cited by 260
Nicotine Inactivation of the Proapoptotic Function of Bax through Phosphorylation
Xin, M., & Deng, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500084200 · Cited by 245
Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., Andrä, M., Matsubayashi, H., Sakai, N., Kohsaka, S., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20850 · Cited by 241
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 240
Jankowsky, J. L., Slunt, H. H., Gonzales, V., Savonenko, A. V., Wen, J. C., Jenkins, N. A., Copeland, N. G., Younkin, L. H., Lester, H. A., Younkin, S. G., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020355 · Cited by 237
Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure
Gentry, C., & Lukas, R. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339184 · Cited by 232
Yao, M., Nguyen, T.-V. V., & Pike, C. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4736-04.2005 · Cited by 231
Williamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie, S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00010.2002 · Cited by 227
Schrattenholz, A., Pereira, E. F., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226
Dementia and Race: Are There Differences Between African Americans and Caucasians?
Miles, T. P., Froehlich, T. E., Bogardus, S. T., & Inouye, S. K. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49096.x · Cited by 225
Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau
Bhaskar, K., Yen, S.-H., & Lee, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505895200 · Cited by 223
Hellström-Lindahl, E., Mousavi, M., Zhang, X., Ravid, R., & Nordberg, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00030-3 · Cited by 215
β-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex
Dougherty, J. J., Wu, J., & Nichols, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06740.2003 · Cited by 214
Link, C. D. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.059 · Cited by 213
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Arneric, S. P., Holladay, M., & Williams, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.033 · Cited by 208
Takada, Y., Yonezawa, A., Kume, T., Katsuki, H., Kaneko, S., Sugimoto, H., & Akaike, A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050104 · Cited by 208
Yao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E., & Coleman, P. D. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00009-8 · Cited by 206
Torroja, L., Chu, H., Kotovsky, I., & White, K. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80215-2 · Cited by 203
Richards, J. G., Higgins, G. A., Ouagazzal, A.-M., Ozmen, L., Kew, J. N. C., Bohrmann, B., Malherbe, P., Brockhaus, M., Loetscher, H., Czech, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08989.2003 · Cited by 202
Martin‐Ruiz, C. M., Court, J. A., Molnar, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S., Ballard, C., Perry, R. H., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731635.x · Cited by 195
Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity
Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T., & Akaike, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00138-3 · Cited by 193
Kaneko, S., Maeda, T., Kume, T., Kochiyama, H., Akaike, A., Shimohama, S., & Kimura, J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00556-8 · Cited by 193
Dajas‐Bailador, F. A., Soliakov, L., & Wonnacott, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00725.x · Cited by 193
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188
Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity
Luheshi, L. M., Tartaglia, G. G., Brorsson, A.-C., Pawar, A. P., Watson, I. E., Chiti, F., Vendruscolo, M., Lomas, D. A., Dobson, C. M., & Crowther, D. C. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050290 · Cited by 187
α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation
Wang, H.-Y., Li, W., Benedetti, N. J., & Lee, D. H. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212532200 · Cited by 185
Takada-Takatori, Y., Kume, T., Sugimoto, M., Katsuki, H., Sugimoto, H., & Akaike, A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.007 · Cited by 185
Preparation of Amyloid β‐Protein for Structural and Functional Studies
Teplow, D. B. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13002-5 · Cited by 184
Bitner, R. S., Bunnelle, W. H., Anderson, D. J., Briggs, C. A., Buccafusco, J., Curzon, P., Decker, M. W., Frost, J. M., Gronlien, J. H., Gubbins, E., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2444-07.2007 · Cited by 184
Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E., & Grando, S. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6191com · Cited by 182
Ritchie, C. W., Ames, D., Clayton, T., & Lai, R. (2004) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200407000-00003 · Cited by 179
Burghaus, L., Schütz, U., Krempel, U., de Vos, R. A. I., Jansen Steur, E. N. H., Wevers, A., Lindstrom, J., & Schröder, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00031-0 · Cited by 178
LINDSTROM, J. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.007 · Cited by 176
Shaw, S., Bencherif, M., & Marrero, M. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204610200 · Cited by 172
Pimlott, S. L., Piggott, M., Owens, J., Greally, E., Court, J. A., Jaros, E., Perry, R. H., Perry, E. K., & Wyper, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300302 · Cited by 169
Arias, E., Gallego-Sandín, S., Villarroya, M., García, A. G., & López, M. G. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090365 · Cited by 169
Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases
Braak, H., Rüb, U., Schultz, C., & Tredici, K. D. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s305 · Cited by 162
Satoh, Y., Endo, S., Ikeda, T., Yamada, K., Ito, M., Kuroki, M., Hiramoto, T., Imamura, O., Kobayashi, Y., Watanabe, Y., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0117-07.2007 · Cited by 162
Chin, J., Palop, J. J., Yu, G.-Q., Kojima, N., Masliah, E., & Mucke, L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0277-04.2004 · Cited by 161
Dajas‐Bailador, F. A., Mogg, A. J., & Wonnacott, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00846.x · Cited by 158
Genistein ameliorates β-amyloid peptide (25–35)-induced hippocampal neuronal apoptosis
Zeng, H., Chen, Q., & Zhao, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.018 · Cited by 158
Wevers, A., Monteggia, L., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J., Pereira, E. F. R., Eisenberg, H., Giacobini, E., De Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 158
Fossgreen, A., Brückner, B., Czech, C., Masters, C. L., Beyreuther, K. T., & Paro, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13703 · Cited by 156
Yu, W., Guan, Z.-Z., Bogdanović, N., & Nordberg, A. K. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.015 · Cited by 155
Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154
Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
Park, H.-J., Lee, P. H., Ahn, Y. W., Choi, Y. J., Lee, G., Lee, D., Chung, E. S., & Jin, B. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05636.x · Cited by 153
Charpantier, E., Wiesner, A., Huh, K.-H., Ogier, R., Hoda, J., Allaman, G., Raggenbass, M., Feuerbach, D., Bertrand, D., & Fuhrer, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3497-05.2005 · Cited by 153
Teaktong, T., Graham, A., Court, J., Perry, R., Jaros, E., Johnson, M., Hall, R., & Perry, E. (2003) · Glia · doi:10.1002/glia.10132 · Cited by 151
Arias, E., Alés, E., Gabilan, N. H., Cano‐Abad, M. F., Villarroya, M., Garcı́a, A. G., & López, M. G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00317-4 · Cited by 151
Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains
Berglund, U. W., & Nordberg, A. K. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00033 · Cited by 149
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148
D’Andrea, M. R., & Nagele, R. G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474224 · Cited by 148
Kadir, A., Almkvist, O., Wall, A. E., Långström, B., & Nordberg, A. K. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0447-7 · Cited by 146
Nicotine Induces Multi-site Phosphorylation of Bad in Association with Suppression of Apoptosis
Jin, Z., Gao, F., Flagg, T. O., & Deng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402566200 · Cited by 144
Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37658-x · Cited by 136
The protein tyrosine kinase, fyn, in Alzheimerʼs disease pathology
Shirazi, S. K., & Wood, J. G. (1993) · Neuroreport · doi:10.1097/00001756-199304000-00024 · Cited by 136
Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation
Cheng, I. H.-J., Palop, J. J., Esposito, L., Bien‐Ly, N., Yan, F., & Mucke, L. (2004) · Nature Medicine · doi:10.1038/nm1123 · Cited by 135
Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake
Chafekar, S. M., Baas, F., & Scheper, W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.003 · Cited by 133
Chemistry-to-gene screens in Caenorhabditis elegans
Jones, A. K., Buckingham, S. D., & Sattelle, D. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1692 · Cited by 130
Self-citationGotti, C., Moretti, M., Bohr, I. J., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I. G., Perry, R. H., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 128
Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity
Bang, O. Y., Hong, H., Kim, D. H., Kim, H., Boo, J. H., Huh, K., & Mook‐Jung, I. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.017 · Cited by 125
Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity
Kihara, T., Sawada, H., Nakamizo, T., Kanki, R., Yamashita, H., Maelicke, A., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.132 · Cited by 124
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody
Bales, K. R., Tzavara, E. T., Wu, S., Wade, M. R., Bymaster, F. P., Paul, S. M., & Nomikos, G. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27120 · Cited by 123
Echeverría, V., Ducatenzeiler, A., Dowd, E., Jänne, J., Grant, S. M., Szyf, M., Wandosell, F. G., Ávila, J., Grimm, H. S., Dunnett, S. B., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.036 · Cited by 121
Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 121
Jonnala, R. R., & Buccafusco, J. J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10022 · Cited by 120
Stevens, T. R., Krueger, S. R., Fitzsimonds, R. M., & Picciotto, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10093.2003 · Cited by 119
Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E
Saavedra, L., Mohamed, A., Ma, V., Kar, S., & de Chaves, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701823200 · Cited by 118
Bell, K. A., O’Riordan, K. J., Sweatt, J. D., & Dineley, K. T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02722.x · Cited by 117
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Zhu, C. W., Scarmeas, N., Torgan, R., Albert, M., Brandt, J., Blacker, D., Sano, M. C., & Stern, Y. (2006) · Neurology · doi:10.1212/01.wnl.0000230160.13272.1b · Cited by 117
Liu, Q., Zhang, J., Zhu, H., Qin, C., Chen, Q., & Zhao, B. (2006) · The FASEB Journal · doi:10.1096/fj.06-5841com · Cited by 113
Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
van Groen, T., Kiliaan, A. J., & Kadish, I. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.010 · Cited by 113
Wu, J., Kuo, Y., George, A. A., Xu, L., Hu, J., & Lukas, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400335200 · Cited by 112
Bi, H., & Sze, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00087-4 · Cited by 111
Grassi, F., Palma, E., Tonini, R., Amici, M., Ballivet, M., & Eusebi, F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.035436 · Cited by 106
Kumar‐Singh, S., Dewachter, I., Moechars, D., Lübke, U., Jonghe, C. D., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P. P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 106
Clementi, M. E., Pezzotti, M., Orsini, F., Sampaolese, B., Mezzogori, D., Grassi, C., Giardina, B., & Misiti, F. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.137 · Cited by 105
Age-Independent Synaptogenesis by Phosphoinositide 3 Kinase
Martín‐Peña, A., Acebes, Á., Rodríguez, J., Sorribes, A., de Polavieja, G. G., Fernández-Fúnez, P., & Ferrús, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1223-06.2006 · Cited by 104
Nicotinic receptor–mediated protection against β-amyloid neurotoxicity
Shimohama, S., & Kihara, T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01100-8 · Cited by 103
Li, Y., Papke, R. L., He, Y., Millard, W. J., & Meyer, E. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01372-4 · Cited by 103
In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
Donnelly‐Roberts, D. L., Xue, I. C., Arnerić, S. P., & Sullivan, J. P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00063-7 · Cited by 101
Sex differences in the hypothalamus in the different stages of human life
Swaab, D. F., Chung, W. C. J., Kruijver, F. P. M., Hofman, M. A., & Hestiantoro, A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00059-9 · Cited by 100
Banerjee, C., Nyengaard, J., Wevers, A., de Vos, R. A., Steur, E. N. J. J., Lindstrom, J., Pilz, K., Nowacki, S., Bloch, W., & Schröder, H. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0317 · Cited by 100
Nicotine blocks TNF-?-mediated neuroprotection to NMDA by an ?-bungarotoxin-sensitive pathway
Carlson, N. G., Bacchi, A., Rogers, S. W., & Gahring, L. C. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199804)35:1<29::aid-neu3>3.0.co;2-d · Cited by 100
Slotkin, T. A., Seidler, F. J., Crain, B. J., Bell, J. M., Bissette, G., & Nemeroff, C. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2452 · Cited by 99
Kumari, S., Borroni, V., Chaudhry, A., Chanda, B., Massol, R., Mayor, S., & Barrantes, F. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709086 · Cited by 95
Xiu, J., Nordberg, A. K., Zhang, J., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.023 · Cited by 91
Rusted, J. M., NEWHOUSE, P. A., & Levin, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00207-2 · Cited by 91
Ho, G. J., Hashimoto, M., Adame, A., Izu, M., Alford, M. F., Thal, L. J., Hansen, L. A., & Masliah, E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.016 · Cited by 90
Expression profiles of multiple genes in single neurons of Alzheimer’s disease
Chow, N., Cox, C., Callahan, L. M., Weimer, J. M., Guo, L., & Coleman, P. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9620 · Cited by 86
Behar, M., Dohlman, H. G., & Elston, T. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703894104 · Cited by 80
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 79
Egea, J., Rosa, A. O., Sobrado, M., Gandía, L., López, M. G., & García, A. G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.036 · Cited by 78
Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors
Abbott, J. J., Howlett, D. R., Francis, P. T., & Williams, R. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.003 · Cited by 76
O'Brien, J. T., Colloby, S. J., Pakrasi, S., Perry, E. K., Pimlott, S. L., Wyper, D., McKeith, I. G., & Williams, E. D. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108209 · Cited by 74
Selective Nicotinic Receptor Consequences in APPSWE Transgenic Mice
Bednar, I., Paterson, D., Marutle, A., Pham, T. M., Svedberg, M. M., Hellström‐Lindahl, E., Mousavi, M. T., COURT, J. A., Morris, C. M., Perry, E. K., et al. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1112 · Cited by 74
Kelly, T. D. (2007) · Frontiers in bioscience · doi:10.2741/2445 · Cited by 73
Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73
Regulation of the Type 1 Inositol 1,4,5-Trisphosphate Receptor by Phosphorylation at Tyrosine 353
Cui, J., Matkovich, S. J., deSouza, N., Li, S., Rosemblit, N., & Marks, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400206200 · Cited by 72
Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells
Hu, M., Waring, J. F., Gopalakrishnan, M., & Li, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05483.x · Cited by 71
Kajta, M., Domin, H., Grynkiewicz, G., & Lasoń, W. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.059 · Cited by 71
Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice
O’Neil, J. N., Mouton, P. R., Tizabi, Y., Ottinger, M. A., Lei, D.-L., Ingram, D. K., & Manaye, K. F. (2007) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2007.05.008 · Cited by 70
Kawasumi, M., Chiba, T., Yamada, M., Miyamae‐Kaneko, M., Matsuoka, M., Nakahara, J., Tomita, T., Iwatsubo, T., Kato, S., Aiso, S., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03397.x · Cited by 70
Gylys, K. H., Fein, J. A., Tan, A. M., & Cole, G. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01643.x · Cited by 70
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders
Buckingham, S. D., Esmaeili, B., Wood, M., & Sattelle, D. B. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh224 · Cited by 70
Self-citationHwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.021 · Cited by 69
Small, D. H., Maksel, D., Kerr, M. L., Ng, J., Hou, X., Chu, C., Mehrani, H., Unabia, S., Azari, M. F., Loiacono, R., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04444.x · Cited by 69
Jeyarasasingam, G., Tompkins, L., & Quik, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00488-2 · Cited by 69
Kim, S., Kim, Y. K., Jeong, S., Haass, C., Kim, Y.-H., & Suh, Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.430 · Cited by 68
Hiramoto, T., Chida, Y., Sonoda, J., Yoshihara, K., Sudo, N., & Kubo, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.005 · Cited by 67
Kume, T., Sugimoto, M., Takada, Y., Yamaguchi, T., Yonezawa, A., Katsuki, H., Sugimoto, H., & Akaike, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.028 · Cited by 62
Mousavi, M. T., Hellström‐Lindahl, E., Guan, Z.-Z., Shan, K.-R., Ravid, R., & Nordberg, A. K. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00460-3 · Cited by 61
Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity
Rowan, M. J., Klyubin, I. V., Wang, Q., & Anwyl, R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.020 · Cited by 60
Hu, M., Schurdak, M. E., Puttfarcken, P. S., Kouhen, R. E., Gopalakrishnan, M., & Li, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.051 · Cited by 60
Wada, T., Naito, M., Kenmochi, H., Tsuneki, H., & Sasaoka, T. (2006) · Endocrinology · doi:10.1210/en.2006-0907 · Cited by 59
β-Amyloid Peptide Activates Non-α7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons
Fu, W., & Jhamandas, J. H. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00616.2003 · Cited by 59
Sabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57
Tozaki‐Saitoh, H., Matsumoto, A., Kanno, T., Nagai, K., Nagata, T., Yamamoto, S., & Nishizaki, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00429-1 · Cited by 57
Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease
Terzano, S., Court, J. A., Fornasari, D., Griffiths, M., Spurden, D., Lloyd, S. R., Perry, R. H., Perry, E. K., & Clementi, F. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00260-5 · Cited by 56
Guan, Z. Z., Miao, H., Tian, J., Unger, C., Nordberg, A. K., & Zhang, X. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100017 · Cited by 56
ERK 1/2 signaling pathway is involved in nicotine‐mediated neuroprotection in spinal cord neurons
Toborek, M. J., Son, K. W., Pudełko, A., King‐Pospisil, K., Wylęgała, E., & Małecki, A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21013 · Cited by 55
Lahiri, D. K., Utsuki, T., Chen, D., Farlow, M. R., Shoaib, M., Ingram, D. K., & Greig, N. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04178.x · Cited by 54
Multiple calcium channels and kinases mediate α7 nicotinic receptor neuroprotection in PC12 cells
Ren, K., Puig, V., Papke, R. L., Itoh, Y., Hughes, J. A., & Meyer, E. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03223.x · Cited by 54
Novel α7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia
Severance, E. G., & Yolken, R. H. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00323.x · Cited by 52
Acetylcholine Protection of Adult Pig Retinal Ganglion Cells from Glutamate-Induced Excitotoxicity
Wehrwein, E. A., Thompson, S. A., Coulibaly, S. F., Linn, D. M., & Linn, C. L. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0406 · Cited by 52
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting
Aguglia, E., Onor, M. L., Saina, M., & Maso, E. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x6273 · Cited by 52
Pym, L. J., Kemp, M., Raymond, V., Buckingham, S. D., Boyd, C. A. R., & Sattelle, D. B. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706403 · Cited by 50
Self-citationQi, X., Nordberg, A. K., Xiu, J., & Guan, Z. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.002 · Cited by 49
Gahring, L. C., Meyer, E. L., & Rogers, S. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02074.x · Cited by 48
Cited by
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Neuroactive Insecticides: Targets, Selectivity, Resistance, and Secondary Effects
Casida, J. E., & Durkin, K. A. (2013) · Annual Review of Entomology · doi:10.1146/annurev-ento-120811-153645 · Cited by 858
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 666
Metadata
- Authors
- Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 61
- Issue
- 1
- Pages
- 39-61
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2159394172
- Cited by
- 308
- References
- 241
- FWCI
- 15.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.